GGACT antibody

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
GGACT antibody
category
Primary Antibodies
provider
FineTest
reference
FNab00013
tested applications
ELISA, WB
Description
AIG2-like domain 1(also known as Gamma-glutamylaminecyclotransferase) contributes to degradation of proteins cross-linked by transglutaminases. It degrades the cross-link between a lysine and a glutamic acid residue from two proteins that have been cross-linked by transglutaminases. It also catalyzes the formation of 5-oxoproline from L-gamma-glutamyl-L-epsilon-lysine.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | AIG2-like domain 1 (GGACT) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | WB: 1:200-1:2000 |
Clonality | polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Observed MW | 17 kDa |
Purity | ≥95% as determined by SDS-PAGE |
Purification | Immunogen affinity purified |
Size 1 | 100µg |
Form | liquid |
Tested Applications | ELISA, WB |
Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
UniProt ID | Q9BVM4 |
Gene ID | 87769 |
Alias | Gamma-glutamylaminecyclotransferase (GGACT),AIG2-like domain-containing protein 1,Gamma-glutamylamine cyclotransferase,GGACT,A2LD1 |
Background | Antibody anti-GGACT |
Status | RUO |
Note | Mol. Weight 17 kDa |
Descripción
Related Products

GGACT antibody
AIG2-like domain 1(also known as Gamma-glutamylaminecyclotransferase) contributes to degradation of proteins cross-linked by transglutaminases. It degrades the cross-link between a lysine and a glutamic acid residue from two proteins that have been cross-linked by transglutaminases. It also catalyzes the formation of 5-oxoproline from L-gamma-glutamyl-L-epsilon-lysine.
Ver Producto
Recombinant Human GGACT
Ver Producto
Gamma-Glutamylamine Cyclotransferase / A2LD1 (GGACT) Antibody
Rabbit Polyclonal against the A2LD1 protein.
Ver Producto